Related Experiment Video
Updated: May 20, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
UK PharmSci 2010: the science of medicines
1School of Pharmacy & Life Sciences, Robert Gordon University, Schoolhill, Aberdeen, UK. k.h.matthews@rgu.ac.uk
Abstract:
This conference was billed as the 'premier conference for pharmaceutical scientists in the UK in 2010 and was organized by the Academy of Pharmaceutical Sciences of Great Britain (APSGB). It was, in fact, the inaugural annual conference of the APSGB and representatives of both academic and industrial institutions were organized to showcase the 'best of pharmaceutical science from the UK and around the world'. A diverse program over 3 days was split into four parallel sessions covering areas such as therapeutics, drug delivery, drug analysis, delivery technology, regenerative medicine, medicinal chemistry and quality by design. Content amounted to a total of 143 podium presentations, 54 by invited speakers and over 90 from selected abstract submissions. Daily poster sessions highlighting 300 separate pieces of original research encircled a trade exhibition by pharmaceutical companies, instrument manufacturers and professional bodies. There appeared to be a consensus that UK PharmSci 2010 was, for 3 days, a worthy forum for the 709 registered delegates based on the feedback given during, and immediately after the event.
More Related Videos
Related Concept Videos
Biopharmaceutics and Pharmacokinetics: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Drug Products: Biologics, Biosimilars and Interchangeables
Pharmaceutical Equivalents

